Modified mRNA is the key to novel anti-cancer therapy, experts offer
Thursday, March 17, 2011 - 22:20
in Health & Medicine
Modern gene therapies raise hopes of combating many diseases until now considered terminal. Today, however, the methods are expensive and carry a risk of severe complications. Modifications to ribonucleic acid mRNA may offer safer and more effective gene drug alternatives. Clinical trials of the first new-generation anti-cancer vaccine will begin later this year.
